HL7 Taiwan has partnered with BestU Co., Ltd. to develop an HL7 FHIR Implementation Guide (IG) for Cancer Insurance Claim Estimation. Based on the HL7 Fast Healthcare Interoperability Resources (FHIRĀ®) standard, the guide helps Taiwanese startups adopt international healthcare information standards and overcome technical barriers to introducing innovative, cross-sector services in healthcare settings. The IG is registered in the HL7 FHIR Implementation Guide Registry (See Figure 1).

The FHIR IG for Cancer Insurance Claim Estimation standardizes key data elements required for cancer diagnosis, treatment, insurance coverage, and claim estimation. Its consistent data format and exchange mechanism enable healthcare institutions to connect existing clinical information more efficiently with insurance claim estimation services, reducing the need to develop customized interfaces for different information systems.
With this application, cancer patients can estimate potential insurance benefits based on relevant clinical information during the treatment decision-making process (See Figures 2 and 3). This allows patients to understand potential claim amounts and out-of-pocket expenses earlier, supporting treatment choices and shared decision-making between patients and healthcare professionals.


The initiative demonstrates how HL7 FHIR can support not only healthcare information exchange but also practical applications in patient services, clinical decision-making, and commercial insurance. It also shows how international standards can facilitate collaboration among healthcare providers, technology companies, and the insurance sector.
Several healthcare institutions in Taiwan have already implemented or participated in insurance claim estimation services, including Taipei Medical University Hospital, Taipei Municipal WanFang Hospital, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University – Hsin Kuo Min Hospital, Pingtung Christian Hospital, and Hungchi Women & Children’s Hospital (See Figure 4). These implementations contribute to the growing body of real-world experience applying FHIR within Taiwanās healthcare ecosystem.

Cancer insurance claim estimation represents the first phase of this standardization initiative. Moving forward, HL7 Taiwan and its partners plan to extend the approach to other diseases, treatment scenarios, and insurance claim use cases. The goal is to establish a reusable, scalable framework that healthcare institutions can adopt more efficiently to meet their clinical and service needs.
HL7 Taiwan will continue to help startups and industry partners develop innovative solutions aligned with international HL7 FHIR standards. By connecting healthcare institutions, technology providers, and the global FHIR community, the affiliate aims to lower system integration barriers, accelerate the implementation of practical digital health solutions, and advance healthcare interoperability, standardization, and international collaboration in Taiwan.
